SAN DIEGO, CA--(Marketwire - August 03, 2010) - Lpath, Inc. (OTCBB: LPTN), the category leader in lipidomics-based therapeutics, will hold a conference call on Thursday, August 5, 2010 at 1:00 p.m. Eastern time to provide a status update and to outline the company’s near-term goals.
Lpath President and CEO Scott Pancoast will host the presentation, followed by a question-and-answer period.
To participate in the call, dial the conference number 5-10 minutes prior to the start time and provide the conference ID provided below.
Date: Thursday, August 5, 2010
Time: 1:00 p.m. Eastern time (10:00 a.m. Pacific time)
Dial-In Number: 1-800-895-0198
International: 1-785-424-1053
Conference ID#: 7LPATH0805
Internet simulcast and replay: http://viavid.net/dce.aspx?sid=00007939
If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.
A telephone replay of the call will be available from 3:00 p.m. Eastern time on the same day until August 12, 2010 by dialing one of following numbers and entering the passcode:
Toll-free replay number: 1-877-870-5176
International replay number: 1-858-384-5517
Passcode: 12021
About Lpath
San Diego-based Lpath, a therapeutic antibody company, is the category leader in lipidomics-based therapeutics, an emerging field of medicine that targets bioactive signaling lipids for treating a wide range of human disease. Lpath’s ImmuneY2™ drug-discovery engine has the unique ability to generate therapeutic antibodies that bind to and inhibit bioactive lipids that contribute to disease. The company is currently advancing three drug candidates, two of which -- ASONEP™ for cancer and iSONEP™ for wet AMD -- have completed Phase I clinical trials and will soon begin Phase II trials. For more information, go to www.Lpath.com.
Lpath, Inc.
Scott R. Pancoast
President & CEO
1-858-678-0800 x104
Email Contact
Lpath Investor Relations
Liolios Group, Inc.
1-949-574-3860
Ron Both:
Email Contact
Geoffrey Plank:
Email Contact
Email Contact
